109
Views
0
CrossRef citations to date
0
Altmetric
Original Articles

Design and Development of a Web-Based Prospective Nationwide Registry for Ocular Inflammatory Diseases: UVEITE.PT – The Portuguese Ocular Inflammation Registry

, MD PhD, , MD, , MD, , MD, , MD, , MD, , MD, , MD, , MD, , MD PhD, , MD, , MD, , MD, , MD PhD, , MD, , MD, , MD, , MD, , MD PhD, , MD PhD, , MD & , MD PhD show all
Pages 342-350 | Received 05 Jul 2022, Accepted 18 Jan 2023, Published online: 13 Feb 2023

References

  • Günther WA, Rezazade Mehrizi MH, Huysman M, Feldberg F. Debating big data: a literature review on realizing value from big data. J Strateg Inf Syst. 2017;26(3):191–209. doi:10.1016/j.jsis.2017.07.003.
  • Oussous A, Benjelloun FZ, Ait Lahcen A, Belfkih S. Big data technologies: a survey. J King Saud Univ - Comput Inf Sci. 2017. doi:10.1016/j.jksuci.2017.06.001.
  • Bhandari R, Hans V, Ahuja NJ. Big data security: challenges, recommendations and solutions. Int J Comput Sci Eng. 2016;4:93–98.
  • Mourao AF, Ribeiro C, Borges J, et al. Real-life effectiveness of Golimumab in biologic-naive patients with rheumatoid arthritis - data from the Rheumatic Diseases Portuguese Register (Reuma.pt). Acta Reumatol Port. 2017;42(Apr–Jun):141–149.
  • Santos MJ, Canhão H, Mourão AF, et al. Reuma.pt contribution to the knowledge of immune-mediated systemic rheumatic diseases. Acta Reumatol Port. 2017;2017(3):232–239.
  • Romão VC, Santos MJ, Polido-Pereira J, et al. Comparative effectiveness of tocilizumab and TNF inhibitors in rheumatoid arthritis patients: data from the Rheumatic Diseases Portuguese Register, Reuma.pt. Biomed Res Int. 2015;2015:1–13. doi:10.1155/2015/279890.
  • Hoque DME, Ruseckaite R, Lorgelly P, Mcneil JJ, Evans SM. Cross-sectional study of characteristics of clinical registries in Australia: a resource for clinicians and policy makers. Int J Qual Heal Care. 2018;30(3):192–199. doi:10.1093/intqhc/mzx196.
  • Liew DFL, Dau J, Robinson PC. Value-Based healthcare in rheumatology: axial spondyloarthritis and beyond. Curr Rheumatol Rep. 2021;23:6. doi:10.1007/S11926-021-01003-Z.
  • Tan JCK, Ferdi AC, Gillies MC, Watson SL. Clinical registries in ophthalmology. Ophthalmology. 2019;126(5):655–662. doi:10.1016/j.ophtha.2018.12.030.
  • Gillies MC, Walton R, Liong J, et al. Efficient capture of high-quality data on outcomes of treatment for macular diseases: the fight retinal blindness! Project. Retina. 2014;34(1):188–195. doi:10.1097/IAE.0B013E318296B271.
  • Lum F, Schachat AP, Jampel HD. The development and demise of a cataract surgery database. Jt Comm J Qual Improv. 2002;28(3):108–114. doi:10.1016/S1070-3241(02)28010-4.
  • Lawlor M, Nguyen V, Brooks A, et al. Efficient capture of high-quality real-world data on treatments for glaucoma: the Fight Glaucoma Blindness! Registry. BMJ Open Ophthalmol. 2021;6(1):e000903. doi:10.1136/bmjophth-2021-000903.
  • Chiang MF, Sommer A, Rich WL, Lum F, Parke DW. The 2016 American Academy of Ophthalmology IRIS® Registry (Intelligent Research in Sight) Database: characteristics and methods. Ophthalmology. 2018;125(8):1143–1148. doi:10.1016/j.ophtha.2017.12.001.
  • Marques JP, Carvalho AL, Henriques J, Murta JN, Saraiva J, Silva R. Design, development and deployment of a web-based interoperable registry for inherited retinal dystrophies in Portugal: the IRD-PT. Orphanet J Rare Dis. 2020;15(1):1–13. doi:10.1186/s13023-020-01591-6.
  • Long M, Tao S, Vega D, Jiang T, Wen Q, Sophia L. Big data and uveitis. Ophthalmology. 2016;8(5):444–454. doi:10.1158/1940-6207.CAPR-14-0359.Nrf2-dependent.
  • Lee RW, Nicholson LB, Sen HN, et al. Autoimmune and autoinflammatory mechanisms in uveitis. Semin Immunopathol. 2014;36(5):581–594. doi:10.1007/s00281-014-0433-9.
  • Durrani OM, Tehrani NN, Marr JE, Moradi P, Stavrou P, Murray PI. Degree, duration, and causes of visual loss in uveitis. Br J Ophthalmol. 2004;88(9):1159–1162. doi:10.1136/bjo.2003.037226.
  • Dick AD, Forrester JV, Liversidge J, Cope AP. The role of tumour necrosis factor (TNF-??) in experimental autoimmune uveoretinitis (EAU). Prog Retin Eye Res. 2004;23(6):617–637. doi:10.1016/j.preteyeres.2004.06.005.
  • Parke IIDW, Lum F, Rich WL. The IRIS® registry. Der Ophthalmol. 2017;114(S1):1–6. doi:10.1007/s00347-016-0265-1.
  • Lee CS, Lee AY, Holland GN, Van Gelder RN, Tufail A. Big data and uveitis. Ophthalmology. 2016;123(11):2273–2275. doi:10.1016/j.ophtha.2016.08.037.
  • Rao P, Lum F, Wood K, et al. Real-World vision in age-related macular degeneration patients treated with single Anti-VEGF drug type for 1 year in the IRIS registry. Ophthalmology. 2017;2:1–7. doi:10.1016/j.ophtha.2017.10.010.
  • Willis J, Morse L, Vitale S, et al. Treatment patterns for myopic choroidal neovascularization in the United States. Ophthalmology. 2017;124(7):935–943. doi:10.1016/j.ophtha.2017.02.018.
  • Research to Prevent Blindness and American Academy of Ophthalmology Award for IRIS Registry Research. Published 2022. https://www.aao.org/iris-registry/data-analysis/research-to-prevent-blindness-research-grants. Accessed July 17, 2021.
  • OpenEyes. https://openeyes.apperta.org. Accessed July 17, 2021.
  • Li JQ, Heinz C, Dell J, Schmid M, Finger RP. Treatment Exit Options for Non-infectious Uveitis (TOFU): study protocol for a prospective clinical registry. Ophthalmic Epidemiol. 2021;1–8. doi:10.1080/09286586.2021.1887285.
  • Vitale A, Della Casa F, Ragab G, et al. Development and implementation of the AIDA International Registry for patients with Behçet’s disease. Intern Emerg Med. 2022;17(7):1977–1986. doi:10.1007/S11739-022-03038-1.
  • Della Casa F, Vitale A, Pereira RM, et al. Development and implementation of the AIDA International Registry for Patients with Non-Infectious Scleritis. Ophthalmol Ther. 2022;11(2):887–897. doi:10.1007/S40123-022-00466-2.
  • Della CF, Vitale A, Guerriero S, et al. Development and implementation of the AIDA International Registry for Patients with Non-Infectious Uveitis. Ophthalmol Ther. 2022;11(2):899–911. doi:10.1007/S40123-022-00459-1.
  • Low R, Chen EJ, Bin Ismail MA, et al. Ocular Autoimmune Systemic Inflammatory Infectious Study (OASIS) - Report 2: pattern of uveitis investigations in Singapore. Ocul Immunol Inflamm. 2020;28(1):92–99. doi:10.1080/09273948.2018.1535080.
  • Chen EJ, Bin Ismail MA, Mi H, et al. Ocular Autoimmune Systemic Inflammatory Infectious Study (OASIS) – report 1: epidemiology and classification. Ocular Immunol Inflammation. 2016;26(5):732–746. doi:10.1080/09273948.2016.1249376.
  • Uveite.pt. https://uveite.pt/uveitis/Login.aspx. Accessed July 17, 2021.
  • Portuguese Society of Ophthalmology. https://spoftalmologia.pt/en/. Accessed July 17, 2021.
  • Canhão H, Faustino A, Martins F, Fonseca JE. Reuma.pt - the rheumatic diseases Portuguese register. Acta Reumatol Port. 2011;36:45–56.
  • Santos MJ, Canhão H, Mourão AF, Oliveira Ramos F, Ponte C, Duarte C, Barcelos A, Martins F, Melo Gomes, JA. Reuma.pt contribution to the knowledge of immune-mediated systemic rheumatic diseases. Acta Reumatol Port. 2017;42(3):232–239.
  • Regulation (EU) 2016/679 of the European Parliament and of the Council of 27 April 2016 on the protection of natural persons with regard to the processing of personal data and on the free movement of such data. Official Journal of the European Union.
  • WebHS. https://www.webhs.pt/en/company/datacenter/. Accessed July 17, 2021.
  • Santos MJ, Canhão H, Faustino A, Fonseca JE. Reuma.pt – a case study. Acta Med Port. 2016;29(2):83. doi:10.20344/amp.7243.
  • Vieira-Sousa E, Alves P, Rodrigues AM, et al. GO-DACT: a phase 3b randomised, double-blind, placebo-controlled trial of GOlimumab plus methotrexate (MTX) versus placebo plus MTX in improving DACTylitis in MTX-naive patients with psoriatic arthritis. Ann Rheum Dis. 2020;79(4):490–498. doi:10.1136/ANNRHEUMDIS-2019-216500.
  • Jabs DA. Standardization of uveitis nomenclature for reporting clinical data. Results of the first international workshop. Am J Ophthalmol. 2005;140(3):509–516. doi:10.1016/j.ajo.2005.03.057.
  • SNOMED International. https://www.snomed.org/snomed-ct/Use-SNOMED-CT. Accessed January 14, 2021.
  • Leal I, Romão VC, Mano S, et al. A non-infectious uveitis multidisciplinary clinic in a tertiary referral center: clinical impact and added value. J Multidiscip Healthc. 2021;14:695–704. doi:10.2147/JMDH.S292981.
  • Cobb AN, Benjamin AJ, Huang ES, Kuo PC. Big data: more than big data sets. Surg (United States). 2018;164(4):640–642. doi:10.1016/j.surg.2018.06.022.
  • Clark A, Ng JQ, Morlet N, Semmens JB. Big data and ophthalmic research. Surv Ophthalmol. 2016;61(4):443–465. doi:10.1016/j.survophthal.2016.01.003.
  • Dick AD, Rosenbaum JT, Al-Dhibi HA, et al. Guidance on noncorticosteroid systemic immunomodulatory therapy in noninfectious uveitis Fundamentals Of Care for UveitiS (FOCUS) Initiative. Ophthalmol. 2018;125(5):757–773. doi:10.1016/j.ophtha.2017.11.017.
  • Kreimeyer K, Foster M, Pandey A, et al. Natural language processing systems for capturing and standardizing unstructured clinical information: a systematic review. J Biomed Inform. 2017;73:14. doi:10.1016/J.JBI.2017.07.012.
  • Koleck TA, Dreisbach C, Bourne PE, Bakken S. Natural language processing of symptoms documented in free-text narratives of electronic health records: a systematic review. J Am Med Inform Assoc. 2019;26(4):364–379. doi:10.1093/JAMIA/OCY173.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.